208 related articles for article (PubMed ID: 15832445)
21. A theoretical validation of the substrate depletion approach to determining kinetic parameters.
Nath A; Atkins WM
Drug Metab Dispos; 2006 Sep; 34(9):1433-5. PubMed ID: 16751261
[TBL] [Abstract][Full Text] [Related]
22. Atypical kinetics of cytochrome P450 enzymes in pharmacology and toxicology.
Leow JWH; Tang LWT; Chan ECY
Adv Pharmacol; 2022; 95():131-176. PubMed ID: 35953154
[TBL] [Abstract][Full Text] [Related]
23. Prediction of cytochrome P450 mediated metabolism.
Olsen L; Oostenbrink C; Jørgensen FS
Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
[TBL] [Abstract][Full Text] [Related]
24. Different enzyme kinetic models.
Seibert E; Tracy TS
Methods Mol Biol; 2014; 1113():23-35. PubMed ID: 24523107
[TBL] [Abstract][Full Text] [Related]
25. Implications of the allosteric kinetics of cytochrome P450s.
Atkins WM
Drug Discov Today; 2004 Jun; 9(11):478-84. PubMed ID: 15149623
[TBL] [Abstract][Full Text] [Related]
26. From electrochemistry to enzyme kinetics of cytochrome P450.
Shumyantseva VV; Kuzikov AV; Masamrekh RA; Bulko TV; Archakov AI
Biosens Bioelectron; 2018 Dec; 121():192-204. PubMed ID: 30218927
[TBL] [Abstract][Full Text] [Related]
27. Comparison between recombinant P450s and human liver microsomes in the determination of cytochrome P450 Michaelis-Menten constants.
Youdim K; Dodia R
Xenobiotica; 2010 Apr; 40(4):235-44. PubMed ID: 20105059
[TBL] [Abstract][Full Text] [Related]
28. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
[TBL] [Abstract][Full Text] [Related]
29. Cytochrome P450 structure-function: insights from molecular dynamics simulations.
Nair PC; McKinnon RA; Miners JO
Drug Metab Rev; 2016 Aug; 48(3):434-52. PubMed ID: 27167388
[TBL] [Abstract][Full Text] [Related]
30. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
[TBL] [Abstract][Full Text] [Related]
31. Cooperative properties of cytochromes P450.
Denisov IG; Frank DJ; Sligar SG
Pharmacol Ther; 2009 Nov; 124(2):151-67. PubMed ID: 19555717
[TBL] [Abstract][Full Text] [Related]
32. Kinetic Modeling of Steady-State Situations in Cytochrome P450 Enzyme Reactions.
Guengerich FP
Drug Metab Dispos; 2019 Nov; 47(11):1232-1239. PubMed ID: 31427434
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450 catalyzed nitric oxide synthesis: a theoretical study.
Keserü GM; Volk B; Balogh GT
J Biomol Struct Dyn; 2000 Feb; 17(4):759-67. PubMed ID: 10698112
[TBL] [Abstract][Full Text] [Related]
34. Substrate inhibition kinetics in drug metabolism reactions.
Wu B
Drug Metab Rev; 2011 Nov; 43(4):440-56. PubMed ID: 21962113
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.
Neve EP; Ingelman-Sundberg M
Curr Opin Drug Discov Devel; 2010 Jan; 13(1):78-85. PubMed ID: 20047148
[TBL] [Abstract][Full Text] [Related]
36. NMR studies of ligand binding to P450(eryF) provides insight into the mechanism of cooperativity.
Roberts AG; Díaz MD; Lampe JN; Shireman LM; Grinstead JS; Dabrowski MJ; Pearson JT; Bowman MK; Atkins WM; Campbell AP
Biochemistry; 2006 Feb; 45(6):1673-84. PubMed ID: 16460014
[TBL] [Abstract][Full Text] [Related]
37. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity.
Nelson SD; Trager WF
Drug Metab Dispos; 2003 Dec; 31(12):1481-98. PubMed ID: 14625345
[TBL] [Abstract][Full Text] [Related]
38. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.
Ekins S; de Groot MJ; Jones JP
Drug Metab Dispos; 2001 Jul; 29(7):936-44. PubMed ID: 11408357
[TBL] [Abstract][Full Text] [Related]
39. Allosteric modulation of substrate motion in cytochrome P450 3A4-mediated xylene oxidation.
Childers WK; Harrelson JP
Biochemistry; 2014 Feb; 53(6):1018-28. PubMed ID: 24476063
[TBL] [Abstract][Full Text] [Related]
40. Rate-limiting steps in cytochrome P450 catalysis.
Guengerich FP
Biol Chem; 2002 Oct; 383(10):1553-64. PubMed ID: 12452431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
